191 related articles for article (PubMed ID: 28917587)
41. Impact of salvage surgery with or without reirradiation for skull base meningiomas recurring after prior radiotherapy.
Rubino F; Schur S; McGovern SL; Kamiya-Matsuoka C; DeMonte F; Raza SM
J Neurosurg; 2023 Sep; 139(3):798-809. PubMed ID: 36738459
[TBL] [Abstract][Full Text] [Related]
42. World Health Organization Grade II Meningiomas: The Role of Adjuvant/Salvage Gamma Knife Surgery After Initial Surgery and Prognostic Factor Assessment.
Liu X; Shan B; Wang M; Xu J
World Neurosurg; 2018 Jan; 109():e352-e362. PubMed ID: 28987849
[TBL] [Abstract][Full Text] [Related]
43. Primary management of atypical meningioma: treatment patterns and survival outcomes by patient age.
Barthélemy E; Loewenstern J; Konuthula N; Pain M; Hall J; Govindaraj S; Bederson J; Shrivastava RK
J Cancer Res Clin Oncol; 2018 May; 144(5):969-978. PubMed ID: 29500705
[TBL] [Abstract][Full Text] [Related]
44. Management trends for anaplastic meningioma with adjuvant radiotherapy and predictors of long-term survival.
Alhourani A; Aljuboori Z; Yusuf M; Woo SY; Hattab EM; Andaluz N; Williams BJ
Neurosurg Focus; 2019 Jun; 46(6):E4. PubMed ID: 31153143
[TBL] [Abstract][Full Text] [Related]
45. Atypical and malignant meningioma: outcome and prognostic factors in 68 irradiated patients.
Detti B; Scoccianti S; Di Cataldo V; Monteleone E; Cipressi S; Bordi L; Pellicanò G; Gadda D; Saieva C; Greto D; Pecchioli G; Buccoliero A; Ceroti M; Ammannati F; Biti G
J Neurooncol; 2013 Dec; 115(3):421-7. PubMed ID: 24045968
[TBL] [Abstract][Full Text] [Related]
46. Survival and failure patterns in atypical and anaplastic meningiomas: A single-center experience of surgery and postoperative radiotherapy.
Kumar N; Kumar R; Khosla D; Salunke PS; Gupta SK; Radotra BD
J Cancer Res Ther; 2015; 11(4):735-9. PubMed ID: 26881510
[TBL] [Abstract][Full Text] [Related]
47. Role of radiation therapy in treating intracranial meningiomas.
Rogers L; Mehta M
Neurosurg Focus; 2007; 23(4):E4. PubMed ID: 17961041
[TBL] [Abstract][Full Text] [Related]
48. Stereotactic radiosurgery versus stereotactic radiotherapy in the management of intracranial meningiomas: a systematic review and meta-analysis.
Fatima N; Meola A; Pollom EL; Soltys SG; Chang SD
Neurosurg Focus; 2019 Jun; 46(6):E2. PubMed ID: 31153149
[TBL] [Abstract][Full Text] [Related]
49. Association Between Facility Volume and Overall Survival for Patients with Grade II Meningioma after Gross Total Resection.
Anakwenze CP; McGovern S; Taku N; Liao K; Boyce-Fappiano DR; Kamiya-Matsuoka C; Ghia A; Chung C; Trifiletti D; Ferguson SD; Li J; Yeboa DN
World Neurosurg; 2020 Sep; 141():e133-e144. PubMed ID: 32407910
[TBL] [Abstract][Full Text] [Related]
50. Impact of timing of radiation therapy on outcomes in atypical meningioma: A clinical audit.
Pant S; Tonse R; Kannan S; Moiyadi A; Shetty P; Epari S; Sahay A; Sastri GJ; Jalali R; Gupta T
Pract Radiat Oncol; 2018; 8(5):e275-e284. PubMed ID: 29861352
[TBL] [Abstract][Full Text] [Related]
51. The Influence of Adjuvant Radiotherapy in Atypical and Anaplastic Meningiomas: A Series of 88 Patients in a Single Institution.
Pisćević I; Villa A; Milićević M; Ilić R; Nikitović M; Cavallo LM; Grujičić D
World Neurosurg; 2015 Jun; 83(6):987-95. PubMed ID: 25769488
[TBL] [Abstract][Full Text] [Related]
52. Brachytherapy with surgical resection as salvage treatment for recurrent high-grade meningiomas: a matched cohort study.
Mooney MA; Bi WL; Cantalino JM; Wu KC; Harris TC; Possatti LL; Juvekar P; Hsu L; Dunn IF; Al-Mefty O; Devlin PM
J Neurooncol; 2020 Jan; 146(1):111-120. PubMed ID: 31745706
[TBL] [Abstract][Full Text] [Related]
53. Major complications from radiotherapy following treatment for atypical meningiomas.
Dawley T; Rana Z; Abou-Al-Shaar H; Goenka A; Schulder M
Neurosurg Focus; 2019 Jun; 46(6):E5. PubMed ID: 31153147
[TBL] [Abstract][Full Text] [Related]
54. Efficacy of radiotherapy and stereotactic radiosurgery as adjuvant or salvage treatment in atypical and anaplastic (WHO grade II and III) meningiomas: a systematic review and meta-analysis.
Gagliardi F; De Domenico P; Snider S; Pompeo E; Roncelli F; Barzaghi LR; Acerno S; Mortini P
Neurosurg Rev; 2023 Mar; 46(1):71. PubMed ID: 36928326
[TBL] [Abstract][Full Text] [Related]
55. Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review.
Kaur G; Sayegh ET; Larson A; Bloch O; Madden M; Sun MZ; Barani IJ; James CD; Parsa AT
Neuro Oncol; 2014 May; 16(5):628-36. PubMed ID: 24696499
[TBL] [Abstract][Full Text] [Related]
56. Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas--clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy.
Adeberg S; Hartmann C; Welzel T; Rieken S; Habermehl D; von Deimling A; Debus J; Combs SE
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):859-64. PubMed ID: 22137023
[TBL] [Abstract][Full Text] [Related]
57. Early postoperative radiotherapy improves progression free survival in patients with grade 2 meningioma.
Aboukais R; Baroncini M; Zairi F; Reyns N; Lejeune JP
Acta Neurochir (Wien); 2013 Aug; 155(8):1385-90; discussion 1390. PubMed ID: 23728501
[TBL] [Abstract][Full Text] [Related]
58. Effectiveness of Postoperative Radiotherapy in Patients with Atypical Meningiomas After Gross Total Resection: Analysis of 260 Cases.
Zeng Q; Tian Z; Gao Q; Xu P; Shi F; Zhang J; Guo Z
World Neurosurg; 2022 Jun; 162():e580-e586. PubMed ID: 35307589
[TBL] [Abstract][Full Text] [Related]
59. Survival Benefit of Adjuvant Radiotherapy in Elderly Patients with WHO Grade III Meningioma.
Zhou H; Bai HX; Chan L; Zhang PJ; Karakousis G; Huang R; Xiao B; Yang L
World Neurosurg; 2019 Nov; 131():e303-e311. PubMed ID: 31356979
[TBL] [Abstract][Full Text] [Related]
60. Atypical meningioma: a study of prognostic factors.
Zaher A; Abdelbari Mattar M; Zayed DH; Ellatif RA; Ashamallah SA
World Neurosurg; 2013 Nov; 80(5):549-53. PubMed ID: 23871812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
